Benecke R.Basic neurophysiological mechanisms in spasticity. In: Marsden D (ed.) Treating spasticity: pharmacological advances . Toronto, Lewiston NY, Bern, Stuttgart: Hans Huber Publishers. 1988;11-19.
2.
Marsden D., Merton PA, Morton HBDirect electrical stimulation of the corticospinal pathways through the intact scalp in human subjects. In: Desmedt JE (ed.) Advances in neurology. New York: Raven Press. 1983;387-391.
3.
Rothwell JCControl of human voluntary movement. Rockville, MD: Aspen Publications, 1987:225.
4.
Young RR, Delwaide PJDrug therapy: spasticity. Part I, NEJM1981 ;304:1:28-33, 96-99.
5.
Burke D.Critical examination of the case for or against fusimotor involvement in disorders of muscle tone. In: Desmendt JE (ed.) Advances in neurology. New York: Raven Press. 1983:39: 133--150.
6.
Rack Pmh, Ross HF, Thilmann AFThe ankle stretch reflexes in normal and spastic subjects. Brain1984;107:637-654.
7.
Powers RK, Ryme WZ, Marder-meyer J.Stretch reflex threshold and velocity dependence in spasticity. Soc Neurosci Abstr1984;10:329.
8.
Lance JWThe control of muscle tone, reflexes, and movement. Neurology1980;30:1303-1313.
9.
Powers RK, Marder-Meyer OT, Rymer WZQuantitative relations between hypertonic and stretch reflex threshold in spastic hemiparesis. Ann Neurol1988;23:115-124.
10.
Liu CN, Chambers WWIntraspinal sprouting of dorsal root axons. Arch Neurol1958;36:46-61.
11.
Rothwell JCControl of human voluntary movement. Rockville, MD: Aspen Publications, 1987:152.
12.
Burke D., Andrews CJ, Lance JWThe tonic vibration reflex in spasticity, Parkinsons Disease and normal man . J Neurol Neurosurg Psychiat1972;35:477-486.
13.
Rymer WZ, Houk JC, Crago PEMechanisms of the clasp-knife reflex. Studies in an animal model. Exp Brain Res1979;37:93-113.
14.
Houk JC, Rymer WZNeural control of muscle length and tension. In: Brooks VB (ed.) Handbook of physiology, sect I, vol II, pt I, Baltimore: Williams and Wilkins, 1981:257-323.
15.
Jenner JR, Stephens JACutaneous reflex responses and their central nervous pathways studied in man . J Physiol1982;333:405-419.
16.
Dietz V., Berger W.Normal and impaired regulation of muscle stiffness in gait: an new hypothesis about muscle hypertonia. Exper Neurol1983 ;79:680-687.
17.
Yanagisawa N., Tanaka R., Ito Z.Reciprocal Ia inhibition in spastic hemiplegia of man. Brain1975;99:555-574.
18.
Katz R., Pierrot-Deseilligny E.Recurrent inhibition of gamma-motoneurones in patients with upper motor neuron lesions. Brain1982;105:103-124.
19.
Ashley P., Andrews C., Knowles L., Lance JWPyramidal and extrapyramidal control of tonic mechanisms in the cat. Brain1972;95:21-30.
20.
Bucy PC, Keplinger JE, Sequiera EBDestruction of the pyramidal tract in man. J Neurosurg1964:21:385-398.
21.
Lawrence DG , Kuypers HGJM. The functional organization of the motor system in the monkey, Parts I and II. Brain1968;91:1-14 and 15-36.
22.
Asanuma H., The pyramidal tract. In: Brooks VB (ed.) Handbook of plysiology, sect I, vol II, pt 2. Baltimore: Williams and Wilkins, 1981;703-733.
23.
Brock LG, Coombs JS, Eccles JCThe recording of potentials from motomeurones with an intracellular electrode . J Physiol1952; 117:431-460.
24.
Eccles JC, Fatt P., Landgren S.The "direct" inhibitory pathway in the spinal cord. Aust J Sci1953;16:130-134.
25.
Davidoff RA , Graham LT, Shanic RP, Werman R., Aprison MHChanges in amino acid concentrations associated with loss of spinal interneurons. J Neurochem1967;14: 1025-1031.
26.
Werman R., Davidoff RA, Aprison MHInhibitory action of glycine on spinal neurons in the cat. J Neurophysiol1968; 31:81-95.
27.
Eccles JCThe inhibitory pathways of the central nervous system. Springfield: Charles C. Thomas, 1969.
28.
Eccles JC, Fatt P., Koketsu K.Cholinergic and inhibitory synapse in a pathway from motor axon collaterals to motoneurones. J Physiol1954;126:524-562.
29.
Schmidt RFPresynaptic inhibition in the vertebrate central nervous system. ErgebPhysiol1971;63:20-101.
30.
Renshaw B.Activity in the simplest spinal reflex pathways. J Neurophysiol1940;3:373-387.
31.
Eccles JC, Eccles RM, Lundberg A.The convergence of monosynaptic excitatory afferents on to many different species of alpha motoneurones. J Physiol1957 ;137:22-50.
32.
Davies J., Watkins JCRole of excitatory amino acid receptors in mono- and polysynaptic excitation in the cat spinal cord. Exp Brain Res1983 ;49:280-290.
33.
Davidoff RAGamma-aminobutyric acid antagonism and presynaptic inhibition in the frog spinal cord. Science1972; 175:331-333.
34.
Willis WDSupraspinal control of ascending pathways. Prog Brain Res1979;50:163-174.
35.
Davidoff RAGamma-aminobutyric acid antagonism and presynaptic inhibition in the frog spinal cord. Science1972; 175:331-333.
36.
Clough Jem, Kernel] D, Phillips CG. The distribution of monosynaptic excitation from the pyramidal tract and primary spindle afferents to motoneurones of the baboon's hand and forearm. J Physiol1968;198:145-66.
37.
Bittiger H.Basic aspects of inhibitory transmitter amino acids in spasticity and pain . In: Marsden D (ed.) Treating spasticity: pharmacological advances. Toronto, LewistonNew York, Bern, Stuttgart: Hans Huber Publisher. 1988; 20-30.
Teng EL, McNeal DR, Krulj A., Waters RLElectrical stimulation and feedback training: effects on the voluntary control of paretic muscles. Arch Phys Med Rehabil1976;57: 228-233.
40.
Vodovnik L., Rebersek S.Improvements in voluntary control of paretic muscles due to electrical stimulation . In: Fields WS, Leavitt LA, eds. Neural organization and its relevance to prosthetics. New York: Intercontinental Medical Books, 1973:101-116.
41.
Rosenfalk A. , Andreassen S.The impaired regulation of force and firing pattern of single motor units in patients with spasticity. J Neurol Neurosurg Psychiat1980;43:907-916.
42.
Tang A., Rymer WZAbnormal force-EMG relations in paretic limbs of hemiparetic human subjects . J Neurol Neurosurg Psychiat1981;44:690-698.
43.
Petajan JHSural nerve stimulation and motor control of tibialis anterior muscle in spastic paresis. Neurology1987;37:47-52.
44.
Kosich D., Molk B., Feeney J., Petajan JHCardiovascular testing and exercise prescription in multiple sclerosis patients . J Neurorehab1987;1: 167-170.